Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

April 01, 2007 (Vol. 27, No. 7)

BioMarket Trends: Promises and Challenges of Pharmacogenetics

Although Robust Growth Is Predicted in the Next Five Years, Mainstream Adoption Is Unclear

  • Pharmacogenetics (PGx), the application of genetic variation to understand variability in medicinal response, has been heralded as the facilitator of personalized medicine and targeted therapies with the potential to alter the healthcare landscape. Key benefits of PGx tools include: · Reducing adverse reactions, enabling selection of optimal therapy, and ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.